Genomics One Corporation (GNX) Announces The Sale Of Its BioCan Scientific Inc. Subsidiaries To Medicorp Inc.
10/19/2005 5:09:45 PM
LAVAL, QC, May 27 /CNW Telbec/ - Genomics One Corporation (TSX Venture Exchange: GNX) announced today that its Board of Directors has approved the terms of a Sale Transaction between Genomics One and Medicorp Inc. of Montreal for the sale of the assets of its BioCan Scientific subsidiaries in Canada and in the US. The Asset Sale Agreement contemplates purchase of all of the trade related assets of BioCan Scientific by Medicorp Inc. The Sale Transaction has a total estimated value of $677,330, all payable in cash.
comments powered by